Dostarlimab (TSR-042) is a humanized anti-PD-1 monoclonal antibody. Dostarlimab binds with high affinity to human PD-1 and competitively inhibits its interaction with its ligands, PD-L1 and PD-L2, with IC50s of 1.8 and 1.5 nM, respectively.
Purity:
>98.0%
CAS Number:
[2022215-59-2]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
